NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients

Timothy Petersen, George I. Papakostas, Kathryn Bottonari, Brian Iacoviello, Jonathan E. Alpert, Maurizio Fava, Andrew A. Nierenberg

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Research in unipolar depression suggests that neuroticism is associated with poor long-term outcome and greater chronicity. The objective of this study was to determine whether baseline neuroticism scores predict response to treatment with fluoxetine in depressed outpatients. Seventy-six depressed outpatients participating in a clinical trial of fluoxetine (fixed/flexible dosing) completed the NEO-FFI (five factor inventory short form) at baseline. Clinical response was defined as a 50% or greater decrease in the 17-item Hamilton Depression Rating Scale (HAM-D-17) total score (final visit - baseline). Logistic regression evaluated NEO-FFI factor scores as predictors of treatment outcome within an intent-to-treat model. Scores on the neuroticism scale were not found to significantly predict treatment response as measured by the HAM-D-17. Strengths of this study include a standardized treatment protocol and use of structured interview instruments, while limitations include a modest sample size, lack of continuation data, state/trait effects, and lack of generalizability to other antidepressant treatments.

Original languageEnglish (US)
Pages (from-to)9-16
Number of pages8
JournalPsychiatry Research
Volume109
Issue number1
DOIs
StatePublished - Jan 31 2002
Externally publishedYes

Fingerprint

Fluoxetine
Outpatients
Depressive Disorder
Clinical Protocols
Sample Size
Antidepressive Agents
Therapeutics
Logistic Models
Clinical Trials
Interviews
Depression
Equipment and Supplies
Research
Neuroticism

Keywords

  • Depression
  • NEO-FFI
  • Neuroticism
  • Personality
  • Response to treatment

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Petersen, T., Papakostas, G. I., Bottonari, K., Iacoviello, B., Alpert, J. E., Fava, M., & Nierenberg, A. A. (2002). NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients. Psychiatry Research, 109(1), 9-16. https://doi.org/10.1016/S0165-1781(01)00359-6

NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients. / Petersen, Timothy; Papakostas, George I.; Bottonari, Kathryn; Iacoviello, Brian; Alpert, Jonathan E.; Fava, Maurizio; Nierenberg, Andrew A.

In: Psychiatry Research, Vol. 109, No. 1, 31.01.2002, p. 9-16.

Research output: Contribution to journalArticle

Petersen, T, Papakostas, GI, Bottonari, K, Iacoviello, B, Alpert, JE, Fava, M & Nierenberg, AA 2002, 'NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients', Psychiatry Research, vol. 109, no. 1, pp. 9-16. https://doi.org/10.1016/S0165-1781(01)00359-6
Petersen, Timothy ; Papakostas, George I. ; Bottonari, Kathryn ; Iacoviello, Brian ; Alpert, Jonathan E. ; Fava, Maurizio ; Nierenberg, Andrew A. / NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients. In: Psychiatry Research. 2002 ; Vol. 109, No. 1. pp. 9-16.
@article{b11e19aabe7f4a75bde5c0f466de8f19,
title = "NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients",
abstract = "Research in unipolar depression suggests that neuroticism is associated with poor long-term outcome and greater chronicity. The objective of this study was to determine whether baseline neuroticism scores predict response to treatment with fluoxetine in depressed outpatients. Seventy-six depressed outpatients participating in a clinical trial of fluoxetine (fixed/flexible dosing) completed the NEO-FFI (five factor inventory short form) at baseline. Clinical response was defined as a 50{\%} or greater decrease in the 17-item Hamilton Depression Rating Scale (HAM-D-17) total score (final visit - baseline). Logistic regression evaluated NEO-FFI factor scores as predictors of treatment outcome within an intent-to-treat model. Scores on the neuroticism scale were not found to significantly predict treatment response as measured by the HAM-D-17. Strengths of this study include a standardized treatment protocol and use of structured interview instruments, while limitations include a modest sample size, lack of continuation data, state/trait effects, and lack of generalizability to other antidepressant treatments.",
keywords = "Depression, NEO-FFI, Neuroticism, Personality, Response to treatment",
author = "Timothy Petersen and Papakostas, {George I.} and Kathryn Bottonari and Brian Iacoviello and Alpert, {Jonathan E.} and Maurizio Fava and Nierenberg, {Andrew A.}",
year = "2002",
month = "1",
day = "31",
doi = "10.1016/S0165-1781(01)00359-6",
language = "English (US)",
volume = "109",
pages = "9--16",
journal = "Psychiatry Research",
issn = "0165-1781",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients

AU - Petersen, Timothy

AU - Papakostas, George I.

AU - Bottonari, Kathryn

AU - Iacoviello, Brian

AU - Alpert, Jonathan E.

AU - Fava, Maurizio

AU - Nierenberg, Andrew A.

PY - 2002/1/31

Y1 - 2002/1/31

N2 - Research in unipolar depression suggests that neuroticism is associated with poor long-term outcome and greater chronicity. The objective of this study was to determine whether baseline neuroticism scores predict response to treatment with fluoxetine in depressed outpatients. Seventy-six depressed outpatients participating in a clinical trial of fluoxetine (fixed/flexible dosing) completed the NEO-FFI (five factor inventory short form) at baseline. Clinical response was defined as a 50% or greater decrease in the 17-item Hamilton Depression Rating Scale (HAM-D-17) total score (final visit - baseline). Logistic regression evaluated NEO-FFI factor scores as predictors of treatment outcome within an intent-to-treat model. Scores on the neuroticism scale were not found to significantly predict treatment response as measured by the HAM-D-17. Strengths of this study include a standardized treatment protocol and use of structured interview instruments, while limitations include a modest sample size, lack of continuation data, state/trait effects, and lack of generalizability to other antidepressant treatments.

AB - Research in unipolar depression suggests that neuroticism is associated with poor long-term outcome and greater chronicity. The objective of this study was to determine whether baseline neuroticism scores predict response to treatment with fluoxetine in depressed outpatients. Seventy-six depressed outpatients participating in a clinical trial of fluoxetine (fixed/flexible dosing) completed the NEO-FFI (five factor inventory short form) at baseline. Clinical response was defined as a 50% or greater decrease in the 17-item Hamilton Depression Rating Scale (HAM-D-17) total score (final visit - baseline). Logistic regression evaluated NEO-FFI factor scores as predictors of treatment outcome within an intent-to-treat model. Scores on the neuroticism scale were not found to significantly predict treatment response as measured by the HAM-D-17. Strengths of this study include a standardized treatment protocol and use of structured interview instruments, while limitations include a modest sample size, lack of continuation data, state/trait effects, and lack of generalizability to other antidepressant treatments.

KW - Depression

KW - NEO-FFI

KW - Neuroticism

KW - Personality

KW - Response to treatment

UR - http://www.scopus.com/inward/record.url?scp=0037204083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037204083&partnerID=8YFLogxK

U2 - 10.1016/S0165-1781(01)00359-6

DO - 10.1016/S0165-1781(01)00359-6

M3 - Article

C2 - 11850046

AN - SCOPUS:0037204083

VL - 109

SP - 9

EP - 16

JO - Psychiatry Research

JF - Psychiatry Research

SN - 0165-1781

IS - 1

ER -